(S029) evaluating the role of a 21-gene expression assay in directing adjuvant radiotherapy decisions for elderly women with early-stage breast cancer
Oncology 29(4 Suppl. 1)
2015
ISSN/ISBN: 0890-9091 PMID: 25930769 Document Number: 679854
Document emailed within 1 workday
Related Documents
Gerson Cwilich, R.; Alban de la Torre, L.F.; Villalobos Prieto, A.; Serrano Olvera, J.A. 2012: Clinicopathological features, prognosis and influence in the adjuvant treatment of the risk recurrence groups determined by the 21 gene expression profile, Oncotype Dx®, in early breast cancer Gaceta Medica de Mexico 148(2): 117-124Spigel, D.R.; Hainsworth, J.D.; Burris, H.A.; Molthrop, D.C.; Peacock, N.; Kommor, M.; Vazquez, E.R.; Greco, F.A.; Yardley, D.A. 2011: A pilot study of adjuvant doxorubicin and cyclophosphamide followed by paclitaxel and sorafenib in women with node-positive or high-risk early-stage breast cancer Clinical Advances in Hematology and Oncology: H&o 9(4): 280-286
2015: (S045) Equivalent Survival With Breast-Conserving Therapy and Mastectomy in Young Women Under the Age of 40 With Early-Stage Breast Cancer: A National Registry-Based Stage-by-Stage Comparison Oncology 29(4 Suppl. 1)
Li, Y.-h.; Tie, J.; Wu, H.; Li, X.-f.; Xu, B.; Cai, Y. 2013: Clinical observation of accelerated partial-breast intensity-modulated radiotherapy in patients with early-stage breast cancer after breast-conserving surgery Zhonghua Yi Xue Za Zhi 93(12): 924-926
Ohsumi, S.; Takashima, S.; Saeki, T.; Aogi, K. 2002: Breast-conserving therapy consisting of wide excision, axillary dissection, and radiotherapy for early-stage breast cancer: the experience of the National Shikoku Cancer Center Biomedicine and PharmacoTherapy 56(Suppl): 196s-200s
Silvestrini, R.; Veneroni, S.; Benini, E.; Daidone, M.G.; Luisi, A.; Leutner, M.; Maucione, A.; Kenda, R.; Zucali, R.; Veronesi, U. 1997: Expression of p53, glutathione S-transferase-pi, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer Journal of the National Cancer Institute 89(9): 639-645
Kanaev, S.V.; Semiglazov, V.F.; Bugrova, I.L.; Vlasov, A.N. 1999: Effectiveness of adjuvant radiotherapy in the conservative treatment of early breast cancer Voprosy Onkologii 45(5): 511-515
Perez, E.; Muss, H.B. 2005: Optimizing adjuvant chemotherapy in early-stage breast cancer Oncology 19(14): 1759-1767; Discussion 1768: 1772-1774; 1777-1778
Tuipae, S.; Yanaranop, M.; Oniem, N. 2012: Role of adjuvant radiotherapy after radical hysterectomy in node-negative stage IB-IIA cervical cancer with intermediate risk factors Journal of the Medical Association of Thailand 95(Suppl 3): S117-S124
Wolff, A.C. 2005: Current status of taxanes as adjuvant therapy for early-stage breast cancer International Journal of Fertility and Women's Medicine 50(5 Pt 1): 227-229
Machin, D.; Andersen, K.W. 1997: Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer Journal of the National Cancer Institute 89(9): 659-660
Donegan, W.L. 1992: Recent trends in the management of breast cancer. 3. Controversies in the use of adjuvant chemotherapy, hormonotherapy and radiotherapy for breast cancer Canadian Journal of Surgery. Journal Canadien de Chirurgie 35(4): 371-377
Nesković-Konstantinović, Z.; Filipović, S. 2003: The role of endocrine therapy in early breast cancer: adjuvant treatment of preand postmenopausal patients Journal of Buon: Official Journal of the Balkan Union of Oncology 8(1): 11-17
Battifora, H.; Gaffey, M.; Esteban, J.; Mehta, P.; Bailey, A.; Faucett, C.; Niland, J. 1991: Immunohistochemical assay of neu/c-erbB-2 oncogene product in paraffin-embedded tissues in early breast cancer: retrospective follow-up study of 245 stage I and II cases Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 4(4): 466-474
Sotnikov, V.M.; Pan'shin, G.A.; Datsenko, P.V.; Ivashin, A.V.; Smol'tsova, N.N. 2009: The role of adjuvant radiotherapy in the complex treatment of stage III-IV aggressive non-Hodgkin's lymphoma Voprosy Onkologii 55(4): 443-446
Horová, H.; Růzicková, J.; Jezková, B.; Horová, I.; Budíková, M.; Dörr, A. 2004: Adjuvant radiotherapy in the therapy of uterine cancer in the first clinical stage Ceska Gynekologie 69(5): 366-371
Kuru, B. 2011: Prognostic factors for locoregional recurrence and survival in stage IIIC breast carcinoma: impact of adjuvant radiotherapy Singapore Medical Journal 52(4): 289-298
1988: Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women New England Journal of Medicine 319(26): 1681-1692
Mitsuyama, S.; Kuroda, Y.; Ohsato, K.; Nakamura, Y.; Murakami, F.; Nishikata, F.; Ikeda, S.; Egami, T.; Mori, A.; Ohe, H. 1996: Administration method and recurrence-preventing effect of medroxyprogesterone acetate (MPA) as a postoperative adjuvant endocrine therapy for stage III breast cancer. Kitakyushu Collaborative Study Group for Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(9): 1153-1160
Marschall, J.; Nechala, P.; Colquhoun, P.; Chibbar, R. 2003: Reassessing the role of axillary lymph-node dissection in patients with early-stage breast cancer Canadian Journal of Surgery. Journal Canadien de Chirurgie 46(4): 285-289